[Therapeutic effectiveness of the Russian drug reaferon in hairy cell leukemia].
The results of the clinical trial of Soviet reaferon in 16 patients with hairy-cell leukemia have been presented. Clinicohematological effect of the drug has been ascertained in 62% of the cases. It has been established that the agent is well-tolerated and produces a good antitumor effect. Doses and regimens of the drug administration to hairy-cell leukemia patients have been developed.
M A
MA
Grigor'eva
A M
AM
Polianskaia
D000328:Adult; D001772:Blood Cell Count / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D014586:USSR
D007370:Interferon Type I
Lechebnaia éffektivnost' otechestvennogo reaferona pri volosato- kletochnom leĭkoze.